ArticleFrontiers in cardiovascular medicine2022
A multi-center, randomized, double-blinded, parallel, placebo-controlled study to assess the efficacy and safety of Shenqisuxin granule in complex coronary artery disease after PCI: Study protocol.
Xiaoping Wu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.